Anker Lundemose

Anker Lundemose serves as Chief Executive Officer at Mission Therapeutics. Mission Therapeutics operates in the research sector with approximately 20.0 employees. The company is headquartered in Cambridge, England. Mission Therapeutics generates annual revenue of 40100000.0. To date, Mission Therapeutics has raised 174015311.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,469 c suite-level executives.

Outlook WordPress.org YouTube Google Font API Typekit Mobile Friendly Wistia Vimeo Remote Circle AI

drug discovery oncology neurodegeneration ubiquitin deubiquitylating enzymes cancer biotechnology research dub drug discovery mitophagy neurodegenerative diseases disease-modifying treatment usp30 clinical development small molecule inhibitors therapeutic targets heart failure parkinsons disease rare mitochondrial diseases fibrosis pipeline clinical candidates first-in-class therapeutics cellular quality control investors collaborative research drug candidates disease-associated dubs scientific culture patient-focused venture capital biotechnology molecular biology drug development biotech innovation research partnerships safety & efficacy biological assays preclinical studies clinical trials academic collaborations fda approval medical breakthroughs targeted therapies protein homeostasis ubiquitin pathway cell health research & development high-impact journals ptential partnerships disruptive biotechnology biopharmaceuticals life sciences drug commercialization therapeutic pipelines patient selection strategy sustainable innovation hospital & health care health care health wellness & fitness

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Anker Lundemose in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Mission Therapeutics.

How do I reach Anker Lundemose directly?

Anker Lundemose's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Mission Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Anker Lundemose work for?

Anker Lundemose is Chief Executive Officer at Mission Therapeutics, a company in the research sector with 20.0 employees. The company is based in Cambridge, England.

Can I pitch or sell to Anker Lundemose?

As Chief Executive Officer at Mission Therapeutics, Anker Lundemose is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Anker Lundemose directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Anker Lundemose in?

Anker Lundemose works in the research industry as Chief Executive Officer at Mission Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Anker Lundemose's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Anker Lundemose's profile is kept up-to-date with the latest available information.

Last updated: May 13, 2026